| Miss Kylie Brooke Werner, MOTR/L | |
|
806 S Kingshighway St, Sikeston, MO 63801-5919 | |
| (573) 471-0110 | |
| Not Available |
| Full Name | Miss Kylie Brooke Werner |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 806 S Kingshighway St, Sikeston, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508128547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2010031856 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Kylie Brooke Werner, MOTR/L 806 S Kingshighway St, Sikeston, MO 63801-5919 Ph: (573) 471-0110 | Miss Kylie Brooke Werner, MOTR/L 806 S Kingshighway St, Sikeston, MO 63801-5919 Ph: (573) 471-0110 |
News Archive
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that Pfizer has agreed to support its pivotal Phase III trial with IMA901, its therapeutic cancer vaccine for advanced renal cell carcinoma.
In a study published in the journal Science last week, a team of researchers at the University of Southampton, led by Andrew Tatem, suggest "the global eradication of malaria could be achieved by individual countries eliminating the disease within their own borders and coordinating efforts regionally," a press release from the University of Southampton reports.
Researchers in the United Kingdom have conducted an extensive survey exploring the impact that lockdown had on people living with low prevalence and young-onset dementias during the first wave of the coronavirus disease 2019 (COVID-19) pandemic.
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology.
Test system on Drosophila should provide the key to histone function. The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism.
› Verified 8 days ago
Jane Kiunisala Apurado, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 821 Auburn Dr, Sikeston, MO 63801 Phone: 573-718-4368 | |
Laura Nicole Duggan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 | |
Julie C Ail, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Mrs. Angela Christine Vandenberghe, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Brittan Rachel Bossert, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0409 | |
Taylor Ann Brotherton, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 113 Holmes Dr, Sikeston, MO 63801 Phone: 573-380-5557 | |
Miss Taralynn Sandker, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Floyd Dr, Sikeston, MO 63801 Phone: 573-472-0397 Fax: 573-472-0406 |